Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case series

Abstract

We postulate that the sequencing of immune checkpoint inhibitors prior to other forms of systemic therapy may potentially lead to an immunomodulatory effect in gastrointestinal cancers with potential improvement in response rates.